MODERNA INC (0QF.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:0QF - US60770K1079 - Common Stock
0QF.DE Key Statistics, Chart & Performance
The current stock price of 0QF.DE is 20.955 EUR. In the past month the price decreased by -4.42%. In the past year, price decreased by -51.33%.
0QF.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1AE.DE | ARGENX SE | 73.44 | 48.25B | ||
| ARGX.BR | ARGENX SE | 71.94 | 47.26B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.24B | ||
| 2X1.DE | ABIVAX SA | N/A | 8.39B | ||
| ABVX.PA | ABIVAX SA | N/A | 8.16B | ||
| GXE.DE | GALAPAGOS NV | N/A | 1.78B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.75B | ||
| 5CV.DE | CUREVAC NV | 5.45 | 1.07B | ||
| NANO.PA | NANOBIOTIX | N/A | 845.70M | ||
| IVA.PA | INVENTIVA SA | N/A | 723.00M | ||
| PHIL.MI | PHILOGEN SPA | 20.26 | 675.44M | ||
| 6IV.DE | INVENTIVA SA | N/A | 651.37M |
Related stock screener links
About 0QF.DE
Company Profile
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 5,800 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
Company Info
MODERNA INC
325 Binney Street
Cambridge MASSACHUSETTS US
Employees: 5800
Phone: 16177146500
MODERNA INC / 0QF.DE FAQ
Can you describe the business of MODERNA INC?
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 5,800 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
What is the current price of 0QF stock?
The current stock price of 0QF.DE is 20.955 EUR. The price decreased by -4.75% in the last trading session.
Does 0QF stock pay dividends?
0QF.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of 0QF stock?
0QF.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of 0QF stock?
MODERNA INC (0QF.DE) operates in the Health Care sector and the Biotechnology industry.
Would investing in MODERNA INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 0QF.DE.
What is the market capitalization of 0QF stock?
MODERNA INC (0QF.DE) has a market capitalization of 8.19B EUR. This makes 0QF.DE a Mid Cap stock.
0QF.DE Technical Analysis
0QF.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE. The financial health of 0QF.DE is average, but there are quite some concerns on its profitability.
0QF.DE Financial Highlights
Over the last trailing twelve months 0QF.DE reported a non-GAAP Earnings per Share(EPS) of -6.93. The EPS decreased by -38.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.68% | ||
| ROE | -33.4% | ||
| Debt/Equity | 0 |
0QF.DE Forecast & Estimates
30 analysts have analysed 0QF.DE and the average price target is 35.55 EUR. This implies a price increase of 69.65% is expected in the next year compared to the current price of 20.955.
For the next year, analysts expect an EPS growth of -7.31% and a revenue growth -41% for 0QF.DE